Efficacy and Safety of Radiotherapy Combined With Tislelizumab and Anlotinib in the Treatment of Hepatocellular Carcinoma Complicated With Portal Vein Tumor Thrombus
Clinical trial NCT07363512 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07363512
- Sponsor
- Henan Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-05
- Primary completion
- 2028-03-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.